Skip to main content

Vaccine Manufacturing and Innovation Centre

Question for Department for Business, Energy and Industrial Strategy

UIN 89571, tabled on 8 December 2021

To ask the Secretary of State for Business, Energy and Industrial Strategy, what the timescales for the sale of the Vaccine Manufacturing Innovation Centre; and whether that matter is subject to the consideration of the National Security and Investment Bill.

This answer is the replacement for a previous holding answer.

Answered on

14 December 2021

The Government’s strategy for vaccine manufacturing and innovation can be found in the Life Sciences Vision policy paper, published in July 2021.

Officials are working closely with the Vaccine Manufacturing Innovation Centre (VMIC) and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. At present, these discussions are commercially sensitive.

The National Security and Investment Act 2021, which comes into force fully on 4 January, gives the Secretary of State powers to intervene in acquisitions of control of certain entities and assets that have given rise to or may give rise to a risk to national security. In addition, the Enterprise Act 2002 was amended in 2020 to allow the Secretary of State to intervene in mergers and takeovers on the public interest grounds of maintaining in the United Kingdom the capability to combat, and to mitigate the effects of, public health emergencies.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.